WEST NILE FEVER
West Nile fever is caused by the West Nile virus (WNV), a mosquito-borne flavivirus and a human, equine, and avian neuropathogen. Birds are the natural reservoir host, and the virus is maintained in nature in a mosquito-bird-mosquito transmission cycle. The virus has also been isolated from dogs.
A serological survey of dogs from the highveld region of South Africa showed that 37% (138 of 377) had neutralising antibodies to WNV (Blackburn et al., 1989). Two of three dogs infected with WNV, had a mild recurrent myopathy, but no other abnormalities were detected in the biochemical or haematological tests performed on any of the dogs. It was concluded that dogs do not play an important role in the epidemiology of WNV, but they possibly contribute to the maintenance of the virus in a region.
West Nile virus has been detected in numerous countries of the Old World, including Africa, Near East and Asia. In Eurasia, WNV has been shown to cause meningoencephalitis in humans and horses (e.g., in Southern France, Romania, Italy and Russia). It first occurred in 1999 in New York City, but has extended its range throughout much of the eastern parts of the USA, and entered South-Central Canada and the Caribbean region.
A study with experimentally infected dogs and cats in 2004 showed viraemia of different extent and no occurrence of clinical signs in dogs and mild, non-neurologic signs in some cats (Austgen et al., 2004). In another study, only serum creatine kinase was altered in infected dogs, suggesting a mild and recurrent myopathy (Blackburn et al., 1989). Generally, WNV infection is suggested not to be associated with clinical disease, especially in dogs, but single case reports of clinical signs and disease have been published (e.g., Lichtensteiger et al., 2003).
Human health risk
Most human infections with WNV are subclinical. If clinical signs occur, flu-like illness can be observed, which is characterized by high fever and chills, malaise, headache, backache and myalgia. In epidemics, fever, a flushed face, conjunctival injection and generalised lymphadenopathy were common. Severe cases exhibit neurological manifestations like meningitis, encephalitis and myelitis.
Austgen LE, Bowen RA, Bunning ML, et al.: Experimental infection of cats and dogs with West Nile virus. Emerg Infect Dis. 2004, 10, 82-6
Blackburn NK, Reyers F, Berry WL, et al.: Susceptibility of dogs to West Nile virus: A survey and pathogenicity trial. J Comp Pathol. 1989, 100, 59-66
Lichtensteiger CA, Heinz-Taheny K, Osborne TS, et al.: West Nile virus encephalitis and myocarditis in wolf and dog. Emerg Infect Dis. 2003, 9, 1303-6
EXPLORE OUR CONTENT
The CVBD Occurence World Map presents country-specific situations based on current scientific knowledge and feed-back from experts around the world in an easy-to-grasped way.
Bayer Animal Health GmbH, an Elanco Animal Health Company, supports education in parasitology and especially in the field of vector-borne diseases. Access picture and video collections, discover the World Forum calendar, interesting links and our glossary.
CVBD World Forum
The CVBD World Forum is a working group of leading international experts with the mission to enhance knowledge and communication on companion animal vector-borne diseases for the improvement of animal, human, and environmental health.